Lung cancer

• Lung Cancer Immunotherapy

  Luis E. Raez, Steven Fein and Eckhard R. Podack

  • Clinical Medicine & Research November 2005, 3 (4)221-228;
  • DOI: https://doi.org/10.3121/cmr.3.4.221
• C-C1-04: Use of Health Plan EMR Data to Identify Chemotherapy Regimens for Advanced Lung Cancer

  Debra Ritzwoller, Nikki Carroll, Thomas Delate, Jared Freml, Mark Hornbrook, Lawrence Kushi and Elizabeth Loggers

  • Clinical Medicine & Research November 2011, 9 (3-4)149-150;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.c-c1-04
• Three Cases of Atypical Breast Metastasis from Lung Adenocarcinoma

  Roshini Ramwani and Jessica Wernberg

  • Clinical Medicine & Research December 2022, 20 (4)231-235;
  • DOI: https://doi.org/10.3121/cmr.2022.1735
• Prognostic Significance of (18) F-Fluorodeoxyglucose – Positron Emission Tomography After Treatment in Patients With Limited Stage Small Cell Lung Cancer

  Adedayo A. Onitilo, Jessica M. Engel, Jennifer M. Demos and Bickol Mukesh

  • Clinical Medicine & Research September 2008, 6 (2)72-77;
  • DOI: https://doi.org/10.3121/cmr.2008.797
• CC4-02: Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer

  Debra Ritzwoller, Lawrence Kushi, Nikki Carroll, Mark Hornbrook, Elizabeth Loggers and Thomas Delate

  • Clinical Medicine & Research August 2012, 10 (3)158;
  • DOI: https://doi.org/10.3121/cmr.2012.1100.cc4-02
• A2-5: Factors Independently Associated with Receiving First-Line Bevacizumab for Advanced Non-Small Cell Lung Cancer

  Thomas Delate, Kimberly Won, Nikki Carroll, Lawrence Kushi, Mark Hornbrook, Erin Bowles and Debra Ritzwoller

  • Clinical Medicine & Research September 2013, 11 (3)124;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.a2-5